1. Home
  2. ARES vs CAH Comparison

ARES vs CAH Comparison

Compare ARES & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARES
  • CAH
  • Stock Information
  • Founded
  • ARES 1997
  • CAH 1979
  • Country
  • ARES United States
  • CAH United States
  • Employees
  • ARES N/A
  • CAH N/A
  • Industry
  • ARES Investment Managers
  • CAH Other Pharmaceuticals
  • Sector
  • ARES Finance
  • CAH Health Care
  • Exchange
  • ARES Nasdaq
  • CAH Nasdaq
  • Market Cap
  • ARES 41.5B
  • CAH 37.6B
  • IPO Year
  • ARES 2014
  • CAH N/A
  • Fundamental
  • Price
  • ARES $181.03
  • CAH $148.01
  • Analyst Decision
  • ARES Buy
  • CAH Buy
  • Analyst Count
  • ARES 15
  • CAH 15
  • Target Price
  • ARES $185.29
  • CAH $159.00
  • AVG Volume (30 Days)
  • ARES 1.3M
  • CAH 2.6M
  • Earning Date
  • ARES 08-01-2025
  • CAH 08-12-2025
  • Dividend Yield
  • ARES 2.47%
  • CAH 1.38%
  • EPS Growth
  • ARES N/A
  • CAH 86.96
  • EPS
  • ARES 1.76
  • CAH 6.45
  • Revenue
  • ARES $4,827,669,000.00
  • CAH $222,578,000,000.00
  • Revenue This Year
  • ARES $17.20
  • CAH $13.11
  • Revenue Next Year
  • ARES $24.20
  • CAH $7.59
  • P/E Ratio
  • ARES $103.24
  • CAH $22.96
  • Revenue Growth
  • ARES 49.87
  • CAH N/A
  • 52 Week Low
  • ARES $110.63
  • CAH $106.54
  • 52 Week High
  • ARES $200.49
  • CAH $168.44
  • Technical
  • Relative Strength Index (RSI)
  • ARES 46.11
  • CAH 38.74
  • Support Level
  • ARES $175.94
  • CAH $147.30
  • Resistance Level
  • ARES $195.26
  • CAH $153.70
  • Average True Range (ATR)
  • ARES 4.95
  • CAH 3.92
  • MACD
  • ARES -1.65
  • CAH -0.23
  • Stochastic Oscillator
  • ARES 26.35
  • CAH 46.87

About ARES Ares Management Corporation

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets, Secondaries Group, and Others. Its Credit Group generates maximum revenue and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate & infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure, & credit.

About CAH Cardinal Health Inc.

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Share on Social Networks: